ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

ClinicalTrials.gov ID: NCT06660173

Public ClinicalTrials.gov record NCT06660173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 7:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM

Study identification

NCT ID
NCT06660173
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
409 participants

Conditions and interventions

Interventions

  • Maridebart Cafraglutide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2024
Primary completion
Oct 5, 2025
Completion
Nov 9, 2026
Last update posted
Nov 24, 2025

2024 – 2026

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Accel Research Site - Birmingham Clinical Research Unit Birmingham Alabama 35216
Anaheim Clinical Trials Anaheim California 92801
Hope Clinical Research LLC Canoga Park California 91303
Orange County Research Center Lake Forest California 92630
San Jose Clinical Trials San Jose California 95128
Northeast Research Institute - Neri Fleming Island Florida 32003
New Horizon Research Center Miami Florida 33165
Florida Institute for Clinical Research Orlando Florida 32825
Conquest Research - Winter Park Winter Park Florida 32789
Accel Research Site - Neurostudies Decatur Georgia 30030
Cedar Crosse Research and Health Care Chicago Illinois 60607
Tandem Clinical Research - Marrero Marrero Louisiana 70072
DM Clinical - Detroit Southfield Michigan 48076
Montana Medical Research Missoula Montana 59808
Physicians East Greenville North Carolina 27834
Diabetes and Endocrinology Associates of Stark County Inc Canton Ohio 44718
Alliance for Multispecialty Research Norman Oklahoma 73069
Trial Management Associates - Myrtle Beach Myrtle Beach South Carolina 29572
FutureSearch Trials of Neurology Austin Texas 78731
Velocity Clinical Research - Dallas Dallas Texas 75230
DM Clinical Research - Cyfair Clinical Research Center Houston Texas 77065
Southern Endocrinology Associates PA Mesquite Texas 75149
Be Well Clinical Studies Round Rock Texas 78681
Diabetes and Glandular Disease Clinic San Antonio Texas 78229
DM Clinical Research - Martin Diagnostic Clinic Tomball Texas 77375
Charlottesville Medical Research Center Charlottesville Virginia 22911
Manassas Clinical Research Center Inc Manassas Virginia 20110
Eastside Research Associates Health Research Redmond Washington 98052

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06660173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2025 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06660173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →